Statistics for Efficacy and Safety of the Proposed Bevacizumab Biosimilar BAT1706 Compared with Reference Bevacizumab In Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
Total visits
| views | |
|---|---|
| Efficacy and Safety of the Proposed Bevacizumab Biosimilar BAT1706 Compared with Reference Bevacizumab In Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study | 0 |
Total visits per month
| views | |
|---|---|
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |